DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE

DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE was reported 3631 times

DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FACTOR V LEIDEN CARRIER 1 0.0909
1 DETRUSOR SPHINCTER DYSSYNERGIA 2 0.0769
2 NERVOUS SYSTEM CYST 2 0.0645
3 SECONDARY TIC 2 0.0488
4 INTRATHECAL PUMP INSERTION 3 0.0361
5 FEEDING TUBE USER 9 0.0246
6 BLOOD PRESSURE ORTHOSTATIC ABNORMAL 3 0.0194
7 FULL BLOOD COUNT 1 0.0175
8 DISRUPTIVE MOOD DYSREGULATION DISORDER 1 0.0135
9 ACTINIC ELASTOSIS 1 0.0132
10 ORTHOSIS USER 3 0.0107
11 INABILITY TO AFFORD MEDICATION 101 0.0102
12 AMYOTROPHIC LATERAL SCLEROSIS 21 0.0097
13 ACUTE MOTOR AXONAL NEUROPATHY 1 0.0096
14 BAND NEUTROPHIL PERCENTAGE INCREASED 1 0.0096
15 UPPER MOTOR NEURONE LESION 2 0.0091
16 BODY HEIGHT ABNORMAL 1 0.0086
17 CERVICAL CORD COMPRESSION 3 0.0083
18 ELECTROCARDIOGRAM QT INTERVAL 1 0.0069
19 PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS 3 0.0062
20 SALIVA DISCOLOURATION 2 0.0060
21 TONGUE MOVEMENT DISTURBANCE 5 0.0058
22 SMALL CELL LUNG CANCER METASTATIC 2 0.0057
23 BLOOD COPPER INCREASED 1 0.0056
24 GAMMOPATHY 1 0.0055
25 BLOOD ZINC DECREASED 1 0.0055
26 REPETITIVE SPEECH 3 0.0053
27 GASTROSTOMY 8 0.0052
28 INAPPROPRIATE AFFECT 8 0.0050
29 CORTISOL ABNORMAL 1 0.0050
30 GOUTY ARTHRITIS 4 0.0050
31 CD8 LYMPHOCYTES DECREASED 1 0.0050
32 ABNORMAL CLOTTING FACTOR 1 0.0049
33 CONDUCT DISORDER 1 0.0049
34 AFFECT LABILITY 45 0.0047
35 FRONTOTEMPORAL DEMENTIA 2 0.0047
36 CORNEAL INFECTION 1 0.0046
37 FINE MOTOR DELAY 1 0.0039
38 BREAST DISORDER FEMALE 1 0.0039
39 EXPULSION OF MEDICATION 2 0.0038
40 ENAMEL ANOMALY 1 0.0035
41 ENTERAL NUTRITION 2 0.0034
42 DEVICE COMPUTER ISSUE 1 0.0033
43 BUTTOCK INJURY 1 0.0033
44 DEFIANT BEHAVIOUR 1 0.0032
45 GASTROINTESTINAL TUBE INSERTION 8 0.0032
46 WHITE MATTER LESION 4 0.0032
47 RESTING TREMOR 2 0.0031
48 FLAT AFFECT 7 0.0030
49 DYSTHYMIC DISORDER 1 0.0030
50 SCREAMING 19 0.0030
51 EPIDURAL LIPOMATOSIS 1 0.0029
52 ORCHITIS 3 0.0028
53 LEGAL PROBLEM 2 0.0027
54 MOANING 3 0.0026
55 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 16 0.0026
56 CARDIOVASCULAR SYMPTOM 1 0.0026
57 VITAMIN B12 INCREASED 2 0.0025
58 DELIRIUM TREMENS 1 0.0025
59 FEAR OF FALLING 2 0.0025
60 CIRCADIAN RHYTHM SLEEP DISORDER 2 0.0024
61 STOMA SITE INFECTION 3 0.0023
62 SELF-DESTRUCTIVE BEHAVIOUR 2 0.0023
63 ELEVATED MOOD 1 0.0023
64 CRYING 83 0.0023
65 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 66 0.0023
66 THERAPY INTERRUPTED 161 0.0023
67 ELECTROCARDIOGRAM ST-T SEGMENT ABNORMAL 1 0.0022
68 ENLARGED UVULA 1 0.0022
69 EXTRAOCULAR MUSCLE PARESIS 1 0.0022
70 LIVING IN RESIDENTIAL INSTITUTION 4 0.0021
71 ELECTROCARDIOGRAM CHANGE 2 0.0021
72 INFUSION SITE NODULE 2 0.0021
73 BLOOD BICARBONATE INCREASED 1 0.0021
74 HYPERVIGILANCE 2 0.0021
75 STARING 5 0.0021
76 GASTRECTOMY 2 0.0020
77 MYOCLONIC EPILEPSY 3 0.0020
78 IMPLANT SITE SWELLING 2 0.0020
79 DAYDREAMING 3 0.0019
80 FLIGHT OF IDEAS 1 0.0019
81 OPHTHALMOPLEGIA 3 0.0019
82 ANTICHOLINERGIC SYNDROME 3 0.0019
83 BINGE EATING 2 0.0019
84 AUTOSCOPY 1 0.0019
85 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 13 0.0018
86 THERAPEUTIC RESPONSE UNEXPECTED 80 0.0018
87 BURNING MOUTH SYNDROME 1 0.0018
88 CATATONIA 9 0.0017
89 JC POLYOMAVIRUS TEST POSITIVE 2 0.0017
90 INSURANCE ISSUE 26 0.0017
91 BLOOD OESTROGEN INCREASED 1 0.0017
92 DERMATILLOMANIA 1 0.0017
93 COLON OPERATION 2 0.0017
94 CRANIOCEREBRAL INJURY 5 0.0017
95 BLADDER PROLAPSE 2 0.0016
96 BLOOD ELECTROLYTES ABNORMAL 2 0.0016
97 BLOOD OSMOLARITY DECREASED 1 0.0016
98 SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS 3 0.0016
99 ANION GAP 1 0.0016
100 FRACTURED COCCYX 2 0.0016
101 ENDOMETRIAL ADENOCARCINOMA 1 0.0016
102 CHALAZION 1 0.0016
103 MUSCLE SPASTICITY 19 0.0015
104 SLOW RESPONSE TO STIMULI 2 0.0015
105 DEVICE BATTERY ISSUE 1 0.0015
106 COMPULSIONS 1 0.0015
107 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 2 0.0015
108 CLUMSINESS 4 0.0015
109 CHANGE OF BOWEL HABIT 3 0.0015
110 ELECTRIC SHOCK SENSATION 4 0.0014
111 CERVICAL RADICULOPATHY 1 0.0014
112 APALLIC SYNDROME 1 0.0014
113 BLOOD FOLATE DECREASED 1 0.0014
114 BRAIN CONTUSION 1 0.0014
115 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 1 0.0014
116 FINGER AMPUTATION 1 0.0014
117 BLUNTED AFFECT 1 0.0014
118 SYMPTOM RECURRENCE 8 0.0013
119 AMPHETAMINES POSITIVE 1 0.0013
120 CARDIAC INFECTION 1 0.0013
121 DISEASE RECURRENCE 63 0.0013
122 CENTRAL NERVOUS SYSTEM LESION 18 0.0013
123 ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY 1 0.0013
124 CRITICAL ILLNESS 1 0.0013
125 GRIMACING 1 0.0013
126 AGGRESSION 63 0.0013
127 URINE FLOW DECREASED 3 0.0013
128 WEIGHT ABNORMAL 3 0.0012
129 SKULL FRACTURE 2 0.0012
130 POSTURE ABNORMAL 4 0.0012
131 MULTIPLE SCLEROSIS RELAPSE 82 0.0012
132 MULTIPLE SCLEROSIS 57 0.0012
133 SEIZURE LIKE PHENOMENA 2 0.0012
134 DEAFNESS TRANSITORY 1 0.0012
135 CRANIOFACIAL FRACTURE 1 0.0012
136 MENOPAUSE 3 0.0012
137 TEARFULNESS 5 0.0012
138 ACTINIC KERATOSIS 3 0.0012
139 DEVICE ALARM ISSUE 2 0.0011
140 LETHARGY 63 0.0011
141 CERUMEN IMPACTION 1 0.0011
142 DRUG DOSE TITRATION NOT PERFORMED 2 0.0011
143 DISTURBANCE IN SEXUAL AROUSAL 1 0.0011
144 CEREBROSPINAL FLUID LEAKAGE 2 0.0011
145 DYSPHAGIA 102 0.0011
146 IMPATIENCE 2 0.0011
147 WALKING AID USER 7 0.0011
148 CEREBRAL PALSY 1 0.0011
149 MOTION SICKNESS 2 0.0010
150 DEMENTIA 29 0.0010
151 THERAPY CESSATION 53 0.0010
152 DEVICE SAFETY FEATURE ISSUE 1 0.0010
153 HOSPICE CARE 10 0.0010
154 TRIGEMINAL NEURALGIA 4 0.0010
155 LOSS OF EMPLOYMENT 3 0.0010
156 FOAMING AT MOUTH 2 0.0010
157 SEROTONIN SYNDROME 19 0.0010
158 HYPERSOMNIA 28 0.0010
159 DEMYELINATION 4 0.0010
160 ANGER 33 0.0010
161 BLADDER DYSFUNCTION 1 0.0010
162 CORONAVIRUS TEST POSITIVE 1 0.0010
163 IMPULSE-CONTROL DISORDER 2 0.0010
164 DELUSION 15 0.0010
165 FAILURE TO THRIVE 5 0.0010
166 APHASIA 29 0.0010
167 BLOOD BLISTER 3 0.0010
168 NEUROGENIC BLADDER 2 0.0009
169 EYE CONTUSION 2 0.0009
170 ABNORMAL BEHAVIOUR 37 0.0009
171 GALLBLADDER ENLARGEMENT 1 0.0009
172 BONE NEOPLASM 1 0.0009
173 CLAUSTROPHOBIA 1 0.0009
174 SEDATION 24 0.0009
175 IMMOBILE 4 0.0009
176 DYSPHEMIA 4 0.0009
177 NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL 3 0.0009
178 PEPTIC ULCER 3 0.0009
179 COMPLEX PARTIAL SEIZURES 1 0.0009
180 AGITATION 65 0.0009
181 DRUG EFFECT VARIABLE 1 0.0009
182 SUDDEN CARDIAC DEATH 3 0.0009
183 FOCAL DYSCOGNITIVE SEIZURES 1 0.0009
184 READING DISORDER 2 0.0009
185 DROOLING 6 0.0009
186 DISTRACTIBILITY 1 0.0009
187 TACHYPHRENIA 3 0.0009
188 BREAKTHROUGH PAIN 2 0.0009
189 NECK SURGERY 2 0.0009
190 TIBIA FRACTURE 4 0.0009
191 DISTURBANCE IN SOCIAL BEHAVIOUR 2 0.0008
192 DECREASED INTEREST 5 0.0008
193 ENERGY INCREASED 5 0.0008
194 BEDRIDDEN 11 0.0008
195 CHRONIC RESPIRATORY FAILURE 1 0.0008
196 SLOW SPEECH 2 0.0008
197 HALLUCINATION, VISUAL 17 0.0008
198 IMPULSIVE BEHAVIOUR 3 0.0008
199 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 1 0.0008
200 PRODUCT USE IN UNAPPROVED INDICATION 195 0.0008
201 SEDATION COMPLICATION 2 0.0008
202 CARDIAC VENTRICULAR THROMBOSIS 1 0.0008
203 CONCUSSION 6 0.0008
204 DRUG CLEARANCE DECREASED 1 0.0008
205 PROSTATOMEGALY 3 0.0008
206 ACTIVITIES OF DAILY LIVING IMPAIRED 15 0.0008
207 INCONTINENCE 8 0.0008
208 MUSCLE RIGIDITY 9 0.0008
209 DYSARTHRIA 28 0.0007
210 HALLUCINATION 56 0.0007
211 BRUXISM 4 0.0007
212 CHONDROPATHY 2 0.0007
213 ANORGASMIA 2 0.0007
214 AGORAPHOBIA 1 0.0007
215 CHOKING 14 0.0007
216 ENDOTRACHEAL INTUBATION 2 0.0007
217 HALLUCINATIONS, MIXED 3 0.0007
218 ATTENTION DEFICIT HYPERACTIVITY DISORDER 3 0.0007
219 PSYCHOTIC DISORDER 21 0.0007
220 MUSCLE FATIGUE 3 0.0007
221 APPENDIX DISORDER 1 0.0007
222 BLADDER DISORDER 7 0.0007
223 JOINT LOCK 2 0.0007
224 GENITAL RASH 1 0.0007
225 MUSCLE TWITCHING 16 0.0007
226 LUNG CANCER METASTATIC 2 0.0007
227 HYPERTONIC BLADDER 2 0.0007
228 FINE MOTOR SKILL DYSFUNCTION 2 0.0007
229 FAT TISSUE INCREASED 1 0.0007
230 GAIT INABILITY 23 0.0007
231 SPEECH DISORDER 36 0.0007
232 PULMONARY PAIN 2 0.0007
233 NECK INJURY 2 0.0007
234 WHEELCHAIR USER 3 0.0007
235 DRUG EFFECT DECREASED 36 0.0007
236 HYPOAESTHESIA ORAL 10 0.0007
237 SELF INJURIOUS BEHAVIOUR 2 0.0007
238 MASTICATION DISORDER 2 0.0007
239 PIGMENTATION DISORDER 4 0.0006
240 FEEDING DISORDER 13 0.0006
241 ELECTROCARDIOGRAM T WAVE ABNORMAL 1 0.0006
242 SEIZURE 74 0.0006
243 FALL 208 0.0006
244 BALANCE DISORDER 54 0.0006
245 FAECAL INCONTINENCE 3 0.0006
246 STUPOR 2 0.0006
247 AORTIC VALVE DISEASE 1 0.0006
248 UNRESPONSIVE TO STIMULI 16 0.0006
249 ANTICONVULSANT DRUG LEVEL INCREASED 1 0.0006
250 FRUSTRATION TOLERANCE DECREASED 5 0.0006
251 MICTURITION URGENCY 7 0.0006
252 REFUSAL OF TREATMENT BY PATIENT 4 0.0006
253 ELECTROCARDIOGRAM QT PROLONGED 22 0.0006
254 SOMNAMBULISM 4 0.0006
255 DYSGRAPHIA 4 0.0006
256 HEAD INJURY 19 0.0006
257 PLANTAR FASCIITIS 2 0.0006
258 FOOD AVERSION 1 0.0006
259 ENTERITIS INFECTIOUS 1 0.0006
260 FACIAL PARALYSIS 5 0.0006
261 EYE MOVEMENT DISORDER 4 0.0006
262 PARANOIA 10 0.0006
263 BLOOD CHLORIDE INCREASED 1 0.0006
264 COGNITIVE DISORDER 27 0.0006
265 FORMICATION 4 0.0006
266 EMOTIONAL POVERTY 1 0.0006
267 LOGORRHOEA 2 0.0006
268 DEPRESSIVE SYMPTOM 2 0.0006
269 NECROTISING FASCIITIS 2 0.0006
270 DYSKINESIA 23 0.0006
271 NYSTAGMUS 3 0.0006
272 HAEMORRHAGE SUBCUTANEOUS 2 0.0006
273 PYODERMA GANGRENOSUM 2 0.0006
274 FACIAL BONES FRACTURE 2 0.0006
275 BEHAVIOUR DISORDER 3 0.0006
276 BIPOLAR DISORDER 6 0.0006
277 PRODUCT PRESCRIBING ISSUE 12 0.0006
278 RESTLESS LEGS SYNDROME 10 0.0005
279 ASPIRATION 6 0.0005
280 NONSPECIFIC REACTION 3 0.0005
281 ESSENTIAL HYPERTENSION 1 0.0005
282 CONDUCTION DISORDER 1 0.0005
283 HYPOMANIA 2 0.0005
284 FREEZING PHENOMENON 2 0.0005
285 URINARY RETENTION 18 0.0005
286 CATHETER PLACEMENT 1 0.0005
287 HEART RATE ABNORMAL 3 0.0005
288 LOSS OF CONTROL OF LEGS 2 0.0005
289 FACE INJURY 2 0.0005
290 COMMUNICATION DISORDER 2 0.0005
291 BOWEL MOVEMENT IRREGULARITY 4 0.0005
292 SUPRAVENTRICULAR TACHYCARDIA 5 0.0005
293 SOCIAL AVOIDANT BEHAVIOUR 3 0.0005
294 SOMNOLENCE 104 0.0005
295 REHABILITATION THERAPY 2 0.0005
296 CONVERSION DISORDER 1 0.0005
297 APNOEA 4 0.0005
298 DYSSTASIA 15 0.0005
299 VITAMIN D DEFICIENCY 5 0.0005
300 HEART RATE DECREASED 18 0.0005
301 MULTIPLE ALLERGIES 4 0.0005
302 ELECTROCARDIOGRAM ABNORMAL 4 0.0005
303 AFFECTIVE DISORDER 4 0.0005
304 PRODUCT USE COMPLAINT 8 0.0005
305 GAIT DISTURBANCE 97 0.0005
306 ATAXIA 6 0.0005
307 PRODUCT USE ISSUE 95 0.0005
308 EMPYEMA 1 0.0005
309 COORDINATION ABNORMAL 7 0.0005
310 PRESCRIBED UNDERDOSE 10 0.0005
311 HEARING IMPAIRED 3 0.0005
312 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 24 0.0005
313 BRAIN INJURY 5 0.0005
314 DEVICE OCCLUSION 7 0.0005
315 ENURESIS 2 0.0005
316 VITAMIN B12 DEFICIENCY 2 0.0005
317 DECUBITUS ULCER 4 0.0005
318 MOTOR DYSFUNCTION 5 0.0005
319 UPPER-AIRWAY COUGH SYNDROME 4 0.0005
320 TEMPERATURE INTOLERANCE 5 0.0005
321 SCOLIOSIS 3 0.0005
322 SOCIAL PROBLEM 2 0.0005
323 AKINESIA 1 0.0005
324 HYPOKINESIA 7 0.0005
325 VENTRICULAR EXTRASYSTOLES 5 0.0005
326 SUICIDAL BEHAVIOUR 2 0.0005
327 PRE-EXISTING CONDITION IMPROVED 3 0.0005
328 SELF-INJURIOUS IDEATION 2 0.0005
329 DEVICE CONNECTION ISSUE 1 0.0005
330 MEMORY IMPAIRMENT 65 0.0005
331 VITAMIN D DECREASED 4 0.0005
332 ALCOHOLISM 2 0.0005
333 CD4 LYMPHOCYTES DECREASED 1 0.0005
334 INCOHERENT 3 0.0005
335 URINARY TRACT INFECTION 79 0.0005
336 MONOPLEGIA 2 0.0005
337 BRADYPHRENIA 3 0.0005
338 TONGUE DISCOLOURATION 2 0.0005
339 PULMONARY FUNCTION TEST DECREASED 2 0.0005
340 BIPOLAR I DISORDER 1 0.0005
341 SARS-COV-2 TEST POSITIVE 6 0.0005
342 EMOTIONAL DISORDER 14 0.0005
343 FAECES PALE 1 0.0004
344 TERMINAL STATE 3 0.0004
345 BACTERIAL TEST POSITIVE 1 0.0004
346 POST-TRAUMATIC STRESS DISORDER 3 0.0004
347 CORNEAL OEDEMA 1 0.0004
348 MENINGITIS ASEPTIC 2 0.0004
349 PAPILLOEDEMA 2 0.0004
350 DRUG EFFECT INCOMPLETE 16 0.0004
351 MOOD SWINGS 14 0.0004
352 MATERNAL EXPOSURE BEFORE PREGNANCY 3 0.0004
353 UROSEPSIS 4 0.0004
354 MOBILITY DECREASED 31 0.0004
355 MUSCULAR WEAKNESS 49 0.0004
356 HAND FRACTURE 3 0.0004
357 BREATH ODOUR 1 0.0004
358 PANCREATIC DISORDER 2 0.0004
359 WITHDRAWAL SYNDROME 17 0.0004
360 ACUTE PSYCHOSIS 1 0.0004
361 FEELING DRUNK 3 0.0004
362 HYPERNATRAEMIA 2 0.0004
363 SALIVARY HYPERSECRETION 4 0.0004
364 FLUID INTAKE REDUCED 2 0.0004
365 MENTAL STATUS CHANGES 11 0.0004
366 DEPRESSION 90 0.0004
367 PRODUCT AVAILABILITY ISSUE 9 0.0004
368 CONTUSION 38 0.0004
369 AORTIC ANEURYSM 3 0.0004
370 BLOOD PRESSURE DIASTOLIC ABNORMAL 1 0.0004
371 WEIGHT LOSS POOR 2 0.0004
372 PERIPHERAL VASCULAR DISORDER 2 0.0004
373 DRUG TITRATION ERROR 1 0.0004
374 TREMOR 64 0.0004
375 SUICIDAL IDEATION 35 0.0004
376 PARTIAL SEIZURES 2 0.0004
377 DRUG SCREEN POSITIVE 3 0.0004
378 DEPRESSED MOOD 20 0.0004
379 MIDDLE INSOMNIA 7 0.0004
380 SENSORY DISTURBANCE 6 0.0004
381 MENTAL IMPAIRMENT 9 0.0004
382 URINARY INCONTINENCE 11 0.0004
383 CONFUSIONAL STATE 60 0.0004
384 DISTURBANCE IN ATTENTION 20 0.0004
385 DECREASED ACTIVITY 4 0.0004
386 TIC 2 0.0004
387 MOOD ALTERED 10 0.0004
388 TREATMENT NONCOMPLIANCE 20 0.0004
389 CLONUS 1 0.0004
390 INTENTIONAL PRODUCT USE ISSUE 32 0.0004
391 MANIA 6 0.0004
392 ABASIA 9 0.0004
393 ASTHENOPIA 2 0.0004
394 DRUG LEVEL BELOW THERAPEUTIC 2 0.0004
395 PRESCRIBED OVERDOSE 7 0.0004
396 ON AND OFF PHENOMENON 2 0.0004
397 DIABETIC COMA 1 0.0004
398 DRUG DOSE OMISSION 59 0.0004
399 ANTIPSYCHOTIC DRUG LEVEL INCREASED 1 0.0004
400 AMNESIA 23 0.0004
401 PERONEAL NERVE PALSY 2 0.0004
402 IMPAIRED DRIVING ABILITY 4 0.0004
403 PARAESTHESIA ORAL 5 0.0003
404 DIPLOPIA 9 0.0003
405 EYELID MARGIN CRUSTING 1 0.0003
406 HYPERVENTILATION 2 0.0003
407 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
408 DRUG INTERACTION 54 0.0003
409 DIZZINESS 169 0.0003
410 CATARACT OPERATION 2 0.0003
411 FACIAL PAIN 3 0.0003
412 CEREBROVASCULAR DISORDER 1 0.0003
413 PLATELET COUNT ABNORMAL 2 0.0003
414 UNEVALUABLE EVENT 25 0.0003
415 OPTIC NEURITIS 3 0.0003
416 NOCTURIA 4 0.0003
417 EYE INJURY 1 0.0003
418 EATING DISORDER 7 0.0003
419 DYSCHEZIA 1 0.0003
420 GRAND MAL CONVULSION 3 0.0003
421 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
422 PRODUCT DISTRIBUTION ISSUE 3 0.0003
423 PERSONALITY CHANGE 3 0.0003
424 FAMILY STRESS 1 0.0003
425 INFUSION SITE EXTRAVASATION 2 0.0003
426 FLANK PAIN 3 0.0003
427 BRAIN FOG 5 0.0003
428 PHOTOPHOBIA 6 0.0003
429 CONDITION AGGRAVATED 96 0.0003
430 BLADDER PAIN 1 0.0003
431 ADVERSE EVENT 29 0.0003
432 HALLUCINATION, AUDITORY 5 0.0003
433 SLEEP APNOEA SYNDROME 6 0.0003
434 MIGRAINE 30 0.0003
435 PRODUCT DOSE OMISSION ISSUE 92 0.0003
436 EXPOSURE TO TOXIC AGENT 1 0.0003
437 LOWER LIMB FRACTURE 6 0.0003
438 HIP FRACTURE 10 0.0003
439 DIZZINESS POSTURAL 3 0.0003
440 BLOOD PRESSURE SYSTOLIC INCREASED 6 0.0003
441 PRODUCT DOSE OMISSION 20 0.0003
442 KIDNEY INFECTION 6 0.0003
443 DEPRESSED LEVEL OF CONSCIOUSNESS 12 0.0003
444 DISORIENTATION 12 0.0003
445 ADVERSE REACTION 4 0.0003
446 BREAST MASS 2 0.0003
447 CEREBRAL HAEMATOMA 1 0.0003
448 EYELID PTOSIS 3 0.0003
449 HEMIPARESIS 5 0.0003
450 SLUGGISHNESS 3 0.0003
451 INITIAL INSOMNIA 3 0.0003
452 AUTOIMMUNE HAEMOLYTIC ANAEMIA 1 0.0003
453 PERIPHERAL COLDNESS 4 0.0003
454 LIMB DISCOMFORT 9 0.0003
455 FUNCTIONAL GASTROINTESTINAL DISORDER 1 0.0003
456 LYMPHOEDEMA 2 0.0003
457 INSOMNIA 77 0.0003
458 DEPRESSION SUICIDAL 1 0.0003
459 SWOLLEN TONGUE 9 0.0003
460 WEIGHT FLUCTUATION 3 0.0003
461 PERIPHERAL SWELLING 44 0.0003
462 EAR PRURITUS 1 0.0003
463 ENCEPHALOPATHY 7 0.0003
464 SCRATCH 3 0.0003
465 JOINT DISLOCATION 3 0.0003
466 TINNITUS 13 0.0003
467 FACIAL PARESIS 1 0.0003
468 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 20 0.0003
469 JOINT INJURY 6 0.0003
470 PRODUCT SUPPLY ISSUE 2 0.0003
471 FRUSTRATION 1 0.0003
472 HEPATIC ENZYME INCREASED 19 0.0003
473 DEVICE KINK 1 0.0003
474 APATHY 4 0.0003
475 CAROTID ARTERY OCCLUSION 1 0.0003
476 BLOOD GLUCOSE FLUCTUATION 3 0.0003
477 MAJOR DEPRESSION 2 0.0003
478 RESTLESSNESS 10 0.0003
479 TOOTH FRACTURE 3 0.0003
480 THERAPEUTIC RESPONSE SHORTENED 9 0.0003
481 BLINDNESS TRANSIENT 2 0.0003
482 ALCOHOL USE 1 0.0003
483 GENERAL SYMPTOM 2 0.0003
484 STATUS EPILEPTICUS 3 0.0003
485 FLUSHING 27 0.0003
486 AUTOIMMUNE THYROIDITIS 1 0.0003
487 POLLAKIURIA 11 0.0003
488 RESPIRATORY FAILURE 19 0.0003
489 VISUAL IMPAIRMENT 32 0.0003
490 PELVIC FRACTURE 2 0.0003
491 BASAL CELL CARCINOMA 4 0.0003
492 MUSCLE SPASMS 47 0.0003
493 SEXUAL DYSFUNCTION 3 0.0003
494 PULMONARY HAEMORRHAGE 2 0.0003
495 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 14 0.0003
496 PRODUCT ADMINISTRATION INTERRUPTED 2 0.0003
497 WEIGHT DECREASED 71 0.0003
498 ABNORMAL DREAMS 7 0.0003
499 BLOOD IRON DECREASED 3 0.0003
500 EXPOSURE VIA BREAST MILK 1 0.0003
501 HYPERLIPIDAEMIA 3 0.0003
502 LOSS OF CONSCIOUSNESS 32 0.0002
503 BLOOD DISORDER 2 0.0002
504 OBSESSIVE-COMPULSIVE DISORDER 2 0.0002
505 MOVEMENT DISORDER 8 0.0002
506 SENSORY LOSS 2 0.0002
507 PRODUCT PHYSICAL ISSUE 5 0.0002
508 FUNGAL SKIN INFECTION 1 0.0002
509 MYASTHENIA GRAVIS 2 0.0002
510 PANIC ATTACK 9 0.0002
511 MUSCLE TIGHTNESS 4 0.0002
512 SCHIZOPHRENIA 3 0.0002
513 BACK DISORDER 4 0.0002
514 ARTHRITIS BACTERIAL 1 0.0002
515 SPINAL OPERATION 3 0.0002
516 EYE DISORDER 8 0.0002
517 ASTHENIA 91 0.0002
518 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 49 0.0002
519 PSYCHOMOTOR HYPERACTIVITY 4 0.0002
520 LIVER FUNCTION TEST ABNORMAL 7 0.0002
521 UPPER GASTROINTESTINAL HAEMORRHAGE 4 0.0002
522 OFF LABEL USE 208 0.0002
523 MUSCLE ATROPHY 3 0.0002
524 BUNDLE BRANCH BLOCK LEFT 1 0.0002
525 RETCHING 5 0.0002
526 IRRITABILITY 14 0.0002
527 ABNORMAL SENSATION IN EYE 1 0.0002
528 CONTRAINDICATED PRODUCT ADMINISTERED 7 0.0002
529 CHAPPED LIPS 1 0.0002
530 BONE CANCER 1 0.0002
531 MENTAL DISORDER 10 0.0002
532 MUSCULOSKELETAL STIFFNESS 20 0.0002
533 SPINAL OSTEOARTHRITIS 2 0.0002
534 GRIP STRENGTH DECREASED 2 0.0002
535 EYE HAEMORRHAGE 3 0.0002
536 CEREBROVASCULAR ACCIDENT 38 0.0002
537 DEATH 192 0.0002
538 ANAL INCONTINENCE 2 0.0002
539 ANXIETY 63 0.0002
540 FEELING ABNORMAL 53 0.0002
541 LEUKOCYTOSIS 4 0.0002
542 LIMB INJURY 6 0.0002
543 DRUG EFFECT DELAYED 1 0.0002
544 IMPAIRED GASTRIC EMPTYING 3 0.0002
545 END STAGE RENAL DISEASE 4 0.0002
546 VISION BLURRED 30 0.0002
547 DISEASE COMPLICATION 1 0.0002
548 EAR DISORDER 1 0.0002
549 RESPIRATORY DISTRESS 6 0.0002
550 INCREASED TENDENCY TO BRUISE 2 0.0002
551 DYSURIA 8 0.0002
552 EYE OPERATION 1 0.0002
553 APHONIA 3 0.0002
554 THINKING ABNORMAL 4 0.0002
555 FEELING OF DESPAIR 1 0.0002
556 VERTIGO 13 0.0002
557 SLEEP DISORDER 15 0.0002
558 LYMPHOPENIA 3 0.0002
559 FOOT FRACTURE 4 0.0002
560 BLOOD URINE PRESENT 4 0.0002
561 NERVOUSNESS 11 0.0002
562 PRODUCT PACKAGING ISSUE 2 0.0002
563 MUSCULOSKELETAL DISORDER 4 0.0002
564 GESTATIONAL DIABETES 1 0.0002
565 PARALYSIS 3 0.0002
566 DIARRHOEA 135 0.0002
567 DRUG INTOLERANCE 20 0.0002
568 PARKINSONISM 2 0.0002
569 VITREOUS FLOATERS 2 0.0002
570 APPLICATION SITE BURN 1 0.0002
571 NIGHTMARE 7 0.0002
572 DISABILITY 4 0.0002
573 SINUS DISORDER 4 0.0002
574 DELIRIUM 7 0.0002
575 EXTRAPYRAMIDAL DISORDER 5 0.0002
576 COLON CANCER 3 0.0002
577 HYPOTONIA 2 0.0002
578 PNEUMONIA ASPIRATION 5 0.0002
579 SYNCOPE 20 0.0002
580 OSTEOPENIA 3 0.0002
581 DRUG TOLERANCE 1 0.0002
582 PARAESTHESIA 31 0.0002
583 DRUG LEVEL DECREASED 2 0.0002
584 NEPHROLITHIASIS 9 0.0002
585 BODY TEMPERATURE INCREASED 4 0.0002
586 EUPHORIC MOOD 2 0.0002
587 FEMORAL NECK FRACTURE 1 0.0002
588 FLATULENCE 11 0.0002
589 ANKLE FRACTURE 3 0.0002
590 NERVOUS SYSTEM DISORDER 6 0.0002
591 FOOD CRAVING 1 0.0002
592 COMA 9 0.0002
593 RESPIRATORY TRACT CONGESTION 3 0.0002
594 HYPOAESTHESIA 28 0.0002
595 FATIGUE 145 0.0002
596 NIGHT SWEATS 6 0.0002
597 FEAR 5 0.0002
598 DYSPNOEA EXERTIONAL 7 0.0002
599 POOR QUALITY SLEEP 4 0.0002
600 SKIN LACERATION 2 0.0002
601 BACK INJURY 2 0.0002
602 OESOPHAGITIS 2 0.0002
603 FAECALOMA 1 0.0002
604 SKIN LESION 5 0.0002
605 HOSPITALISATION 28 0.0002
606 CHOKING SENSATION 1 0.0002
607 STEVENS-JOHNSON SYNDROME 4 0.0002
608 NECK PAIN 10 0.0002
609 SNEEZING 4 0.0002
610 SKIN INFECTION 2 0.0002
611 CANDIDA INFECTION 3 0.0002
612 TARDIVE DYSKINESIA 5 0.0002
613 CHOLECYSTITIS ACUTE 1 0.0002
614 INTERNATIONAL NORMALISED RATIO INCREASED 5 0.0002
615 CHOLECYSTECTOMY 2 0.0002
616 BLOOD URIC ACID INCREASED 1 0.0002
617 GENERAL PHYSICAL HEALTH DETERIORATION 20 0.0002
618 DECREASED APPETITE 40 0.0002
619 DYSPHONIA 10 0.0002
620 HEAD DISCOMFORT 3 0.0002
621 COVID-19 PNEUMONIA 2 0.0002
622 ROAD TRAFFIC ACCIDENT 7 0.0002
623 ADVERSE DRUG REACTION 15 0.0002
624 WRIST FRACTURE 2 0.0002
625 SUICIDE ATTEMPT 10 0.0002
626 BONE DISORDER 3 0.0002
627 NEURALGIA 4 0.0002
628 EPILEPSY 5 0.0002
629 FEELING HOT 10 0.0002
630 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
631 DRY MOUTH 13 0.0002
632 BLOOD SODIUM DECREASED 3 0.0002
633 CELLULITIS 8 0.0002
634 INCREASED APPETITE 3 0.0002
635 FOREIGN BODY SENSATION IN EYES 1 0.0002
636 BURNING SENSATION 11 0.0002
637 HYPOPHAGIA 4 0.0002
638 POST PROCEDURAL COMPLICATION 3 0.0002
639 HYPERHIDROSIS 20 0.0002
640 CARDIAC FLUTTER 1 0.0002
641 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 11 0.0002
642 HIATUS HERNIA 2 0.0002
643 HAEMATOMA 4 0.0002
644 SWELLING FACE 10 0.0002
645 PULMONARY CONGESTION 2 0.0002
646 CORONAVIRUS INFECTION 1 0.0002
647 VOMITING 71 0.0002
648 BLOOD PRESSURE ABNORMAL 3 0.0002
649 EXPIRED PRODUCT ADMINISTERED 5 0.0002
650 LIP SWELLING 5 0.0001
651 ATRIOVENTRICULAR BLOCK COMPLETE 1 0.0001
652 QUALITY OF LIFE DECREASED 2 0.0001
653 JAUNDICE 4 0.0001
654 INTENTIONAL SELF-INJURY 3 0.0001
655 HEADACHE 93 0.0001
656 TRANSIENT ISCHAEMIC ATTACK 5 0.0001
657 PALLOR 4 0.0001
658 ACUTE HEPATIC FAILURE 2 0.0001
659 TACHYCARDIA 13 0.0001
660 BLOOD TESTOSTERONE DECREASED 1 0.0001
661 RIB FRACTURE 3 0.0001
662 CORONARY ARTERY OCCLUSION 2 0.0001
663 GASTRIC DISORDER 5 0.0001
664 DRUG INEFFECTIVE 192 0.0001
665 ORAL DISCOMFORT 2 0.0001
666 DISEASE PROGRESSION 17 0.0001
667 HUNGER 2 0.0001
668 CARPAL TUNNEL SYNDROME 2 0.0001
669 SKIN REACTION 2 0.0001
670 EYE PAIN 8 0.0001
671 HYPERTENSION 30 0.0001
672 SEASONAL ALLERGY 2 0.0001
673 PRODUCT DOSE OMISSION IN ERROR 4 0.0001
674 NAUSEA 111 0.0001
675 SUBDURAL HAEMATOMA 2 0.0001
676 OEDEMA PERIPHERAL 17 0.0001
677 HYPOACUSIS 6 0.0001
678 PRURITUS GENERALISED 3 0.0001
679 FAECES DISCOLOURED 3 0.0001
680 DERMATITIS BULLOUS 1 0.0001
681 NO ADVERSE EVENT 25 0.0001
682 FAECES SOFT 1 0.0001
683 ABDOMINAL DISCOMFORT 23 0.0001
684 UNDERDOSE 10 0.0001
685 PALPITATIONS 16 0.0001
686 ACUTE MYOCARDIAL INFARCTION 4 0.0001
687 COUGH 38 0.0001
688 GLOSSODYNIA 3 0.0001
689 WEIGHT INCREASED 30 0.0001
690 INFLUENZA LIKE ILLNESS 11 0.0001
691 MUSCULOSKELETAL PAIN 7 0.0001
692 CHROMATURIA 3 0.0001
693 HOT FLUSH 10 0.0001
694 BRADYCARDIA 7 0.0001
695 ILL-DEFINED DISORDER 8 0.0001
696 DISCOMFORT 8 0.0001
697 DRUG ADMINISTRATION ERROR 4 0.0001
698 ATRIOVENTRICULAR BLOCK 1 0.0001
699 OEDEMA 7 0.0001
700 MALAISE 56 0.0001
701 FURUNCLE 1 0.0001
702 PRODUCT PRESCRIBING ERROR 3 0.0001
703 GINGIVAL PAIN 1 0.0001
704 INFLUENZA 14 0.0001
705 OBESITY 2 0.0001
706 SEPSIS 14 0.0001
707 ABSCESS 2 0.0001
708 ATRIAL FLUTTER 1 0.0001
709 ABDOMINAL DISTENSION 13 0.0001
710 CONSTIPATION 27 0.0001
711 PNEUMONIA 40 0.0001
712 EXTRA DOSE ADMINISTERED 5 0.0001
713 BLOOD POTASSIUM INCREASED 2 0.0001
714 GASTROINTESTINAL DISORDER 11 0.0001
715 CONVULSION 7 0.0001
716 ABNORMAL FAECES 1 0.0001
717 HERPES ZOSTER 7 0.0001
718 BRONCHITIS 9 0.0001
719 ESCHERICHIA INFECTION 1 0.0001
720 OSTEOPOROSIS 5 0.0001
721 STAPHYLOCOCCAL INFECTION 4 0.0001
722 HEART RATE INCREASED 12 0.0001
723 VENTRICULAR TACHYCARDIA 2 0.0001
724 VISUAL ACUITY REDUCED 4 0.0001
725 AGEUSIA 3 0.0001
726 SKIN DISORDER 4 0.0001
727 RASH 52 0.0001
728 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
729 PAIN IN EXTREMITY 35 0.0001
730 HYPERSENSITIVITY 22 0.0001
731 CARDIOVASCULAR DISORDER 3 0.0001
732 BLOOD PRESSURE INCREASED 18 0.0001
733 HEPATITIS 3 0.0001
734 CHEST DISCOMFORT 12 0.0001
735 BLOOD MAGNESIUM DECREASED 1 0.0001
736 CARDIAC MURMUR 1 0.0001
737 ORTHOSTATIC HYPOTENSION 2 0.0001
738 LYMPHADENOPATHY 4 0.0001
739 DEHYDRATION 15 0.0001
740 CARDIAC FAILURE CONGESTIVE 9 0.0001
741 GALLBLADDER DISORDER 2 0.0001
742 ALOPECIA 22 0.0001
743 THIRST 2 0.0001
744 GASTROINTESTINAL INFECTION 1 0.0001
745 THROAT IRRITATION 5 0.0001
746 FREQUENT BOWEL MOVEMENTS 3 0.0001
747 MYOCARDIAL INFARCTION 19 0.0001
748 RESPIRATORY ARREST 3 0.0001
749 BLOOD GLUCOSE ABNORMAL 2 0.0001
750 RENAL DISORDER 5 0.0001
751 BLOOD CHOLESTEROL INCREASED 5 0.0001
752 ERYTHEMA MULTIFORME 1 0.0001
753 APPENDICITIS 1 0.0001
754 SWELLING 10 0.0001
755 ARTERIOSCLEROSIS 1 0.0001
756 ASTHMA 12 0.0001
757 PAIN 65 0.0001
758 COLITIS 4 0.0001
759 CHRONIC KIDNEY DISEASE 8 0.0001
760 EYE INFLAMMATION 1 0.0001
761 ATELECTASIS 1 0.0001
762 ERUCTATION 2 0.0001
763 COVID-19 18 0.0001
764 AUTOIMMUNE DISORDER 1 0.0001
765 ORAL HERPES 2 0.0001
766 SURGERY 6 0.0001
767 NASAL CONGESTION 6 0.0001
768 LABORATORY TEST ABNORMAL 3 0.0001
769 EMBEDDED DEVICE 1 0.0001
770 UPPER LIMB FRACTURE 2 0.0001
771 ABORTION SPONTANEOUS 4 0.0001
772 SPINAL FRACTURE 2 0.0001
773 BLOOD POTASSIUM DECREASED 3 0.0001
774 INJURY 7 0.0001
775 LACRIMATION INCREASED 3 0.0001
776 EMPHYSEMA 1 0.0001
777 BACK PAIN 23 0.0001
778 BLINDNESS 4 0.0001
779 CHEST PAIN 18 0.0001
780 CARDIAC DISORDER 9 0.0001
781 DERMATITIS 2 0.0001
782 FULL BLOOD COUNT ABNORMAL 1 0.0001
783 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
784 EPISTAXIS 7 0.0001
785 IMPAIRED WORK ABILITY 2 0.0001
786 BODY HEIGHT DECREASED 1 0.0001
787 LIVER FUNCTION TEST INCREASED 2 0.0001
788 SKIN CANCER 2 0.0001
789 OVERDOSE 20 0.0001
790 ATRIAL FIBRILLATION 9 0.0001
791 NASOPHARYNGITIS 17 0.0001
792 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
793 GASTROINTESTINAL PAIN 1 0.0001
794 HYPOTENSION 18 0.0001
795 URTICARIA 15 0.0001
796 THROMBOCYTOPENIA 10 0.0001
797 PULMONARY OEDEMA 4 0.0001
798 EYE PRURITUS 3 0.0001
799 BLISTER 5 0.0001
800 PANCREATITIS ACUTE 2 0.0001
801 BLOOD CALCIUM DECREASED 1 0.0001
802 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 16 0.0001
803 EYE INFECTION 1 0.0001
804 HEART RATE IRREGULAR 2 0.0001
805 DYSPNOEA 50 0.0001
806 DERMATITIS CONTACT 1 0.0001
807 ABDOMINAL PAIN UPPER 18 0.0001
808 SKIN DISCOLOURATION 4 0.0001
809 THROMBOSIS 7 0.0001
810 GASTRIC HAEMORRHAGE 1 0.0001
811 ELECTROLYTE IMBALANCE 1 0.0001
812 ACUTE KIDNEY INJURY 13 0.0001
813 CARDIAC ARREST 7 0.0001
814 PULMONARY EMBOLISM 8 0.0001
815 NEUROPATHY PERIPHERAL 8 0.0001
816 CATARACT 5 0.0001
817 ACCIDENT 1 0.0001
818 DIABETIC KETOACIDOSIS 2 0.0001
819 HEPATIC CANCER 2 0.0001
820 LOCALISED INFECTION 2 0.0001
821 FIBROMYALGIA 2 0.0001
822 PRESYNCOPE 2 0.0001
823 CARDIOMEGALY 1 0.0001
824 ABNORMAL WEIGHT GAIN 1 0.0001
825 DYSGEUSIA 6 0.0001
826 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
827 DRY EYE 4 0.0001
828 INTESTINAL OBSTRUCTION 3 0.0001
829 BRAIN OEDEMA 1 0.0001
830 ABDOMINAL PAIN LOWER 2 0.0001
831 PYREXIA 27 0.0001
832 ERECTILE DYSFUNCTION 2 0.0001
833 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 4 0.0001
834 HAEMORRHAGE 8 0.0001
835 ARTHRITIS 6 0.0001
836 GASTRITIS 2 0.0001
837 ANKYLOSING SPONDYLITIS 1 0.0001
838 DERMATITIS ATOPIC 4 0.0001
839 PANCREATITIS 4 0.0001
840 ASPARTATE AMINOTRANSFERASE INCREASED 4 0.0001
841 BLOOD PRESSURE DECREASED 5 0.0001
842 PLATELET COUNT DECREASED 8 0.0001
843 NEOPLASM MALIGNANT 5 0.0001
844 JOINT SWELLING 9 0.0001
845 GASTROOESOPHAGEAL REFLUX DISEASE 6 0.0001
846 THROAT TIGHTNESS 2 0.0001
847 DEVICE BREAKAGE 3 0.0001
848 WHITE BLOOD CELL COUNT DECREASED 8 0.0001
849 AKATHISIA 1 0.0001
850 ABDOMINAL PAIN 17 0.0001
851 ARTHROPATHY 4 0.0001
852 WOUND 2 0.0001
853 INCORRECT DRUG ADMINISTRATION DURATION 2 0.0001
854 HYPONATRAEMIA 4 0.0001
855 BLINDNESS UNILATERAL 1 0.0001
856 INTENTIONAL DOSE OMISSION 2 0.0001
857 INCORRECT DOSE ADMINISTERED 16 0.0001
858 BRONCHOSPASM 1 0.0001
859 ANGINA PECTORIS 2 0.0001
860 ARTHRALGIA 29 0.0001
861 EYE IRRITATION 4 0.0001
862 ANOSMIA 1 0.0001
863 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
864 GASTROENTERITIS 1 0.0001
865 CHILLS 8 0.0001
866 ILLNESS 7 0.0001
867 ANGIOEDEMA 3 0.0001
868 RENAL FAILURE 9 0.0001
869 CARDIOMYOPATHY 1 0.0001
870 LIVER DISORDER 3 0.0001
871 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
872 DRY SKIN 9 0.0001
873 RENAL INJURY 2 0.0001
874 THERAPEUTIC PRODUCT EFFECT DECREASED 3 0.0001
875 STOMATITIS 4 0.0001
876 DRUG DISPENSING ERROR 1 0.0001
877 ALANINE AMINOTRANSFERASE INCREASED 4 0.0001
878 DEVICE RELATED INFECTION 1 0.0001
879 FEMUR FRACTURE 2 0.0001
880 ARRHYTHMIA 3 0.0001
881 PRODUCTIVE COUGH 3 0.0001
882 CYSTITIS 2 0.0001
883 METABOLIC ACIDOSIS 2 0.0001
884 INTENTIONAL OVERDOSE 4 0.0001
885 RHINORRHOEA 4 0.0001
886 DEEP VEIN THROMBOSIS 4 0.0001
887 CHOLELITHIASIS 2 0.0001
888 IMPAIRED HEALING 2 0.0001
889 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
890 DRUG LEVEL INCREASED 1 0.0001
891 COAGULOPATHY 1 0.0001
892 FUNGAL INFECTION 2 0.0001
893 BLOOD UREA INCREASED 1 0.0001
894 FACE OEDEMA 1 0.0001
895 FLUID RETENTION 3 0.0001
896 MYALGIA 10 0.0001
897 HAEMATURIA 2 0.0001
898 INJECTION SITE REACTION 4 0.0001
899 NEOPLASM PROGRESSION 2 0.0001
900 HYPERKALAEMIA 2 0.0001
901 AMENORRHOEA 1 0.0001
902 COLD SWEAT 1 0.0001
903 SYSTEMIC LUPUS ERYTHEMATOSUS 2 0.0001
904 CEREBRAL HAEMORRHAGE 2 0.0001
905 GASTROENTERITIS VIRAL 1 0.0001
906 RASH PRURITIC 3 0.0001
907 INFECTION 8 0.0001
908 ACCIDENTAL OVERDOSE 2 0.0001
909 HAEMATOCHEZIA 3 0.0001
910 EYE SWELLING 2 0.0001
911 BACTERIAL INFECTION 1 0.0001
912 OXYGEN SATURATION DECREASED 3 0.0001
913 FRACTURE 1 0.0001
914 GASTRIC ULCER 1 0.0001
915 FEELING JITTERY 1 0.0001
916 ACUTE RESPIRATORY FAILURE 1 0.0001
917 DYSTONIA 1 0.0001
918 DYSPEPSIA 5 0.0001
919 COMPLICATION OF DEVICE INSERTION 1 0.0001
920 PLEURAL EFFUSION 3 0.0000
921 SINUSITIS 5 0.0000
922 ERYTHEMA 10 0.0000
923 OSTEOARTHRITIS 2 0.0000
924 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
925 VAGINAL HAEMORRHAGE 2 0.0000
926 DEVICE DISLOCATION 2 0.0000
927 INTENTIONAL PRODUCT MISUSE 4 0.0000
928 APPLICATION SITE PAIN 1 0.0000
929 MATERNAL EXPOSURE DURING PREGNANCY 4 0.0000
930 PRODUCT QUALITY ISSUE 6 0.0000
931 APPLICATION SITE PRURITUS 1 0.0000
932 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
933 SKIN IRRITATION 2 0.0000
934 OROPHARYNGEAL PAIN 4 0.0000
935 BREAST CANCER 4 0.0000
936 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 2 0.0000
937 BLOOD PRESSURE FLUCTUATION 1 0.0000
938 PRURITUS 16 0.0000
939 HYPOGLYCAEMIA 2 0.0000
940 LEUKOPENIA 2 0.0000
941 HAEMOGLOBIN DECREASED 4 0.0000
942 DRUG RESISTANCE 1 0.0000
943 ANAPHYLACTIC SHOCK 1 0.0000
944 INFLAMMATION 2 0.0000
945 DEAFNESS 1 0.0000
946 APPLICATION SITE ERYTHEMA 1 0.0000
947 ANHEDONIA 1 0.0000
948 EAR INFECTION 1 0.0000
949 BREAST CANCER FEMALE 1 0.0000
950 DRUG DEPENDENCE 6 0.0000
951 BLOOD GLUCOSE INCREASED 7 0.0000
952 ANAEMIA 7 0.0000
953 ANAPHYLACTIC REACTION 2 0.0000
954 DIVERTICULITIS 1 0.0000
955 FEELING COLD 1 0.0000
956 RENAL IMPAIRMENT 3 0.0000
957 PRODUCT STORAGE ERROR 3 0.0000
958 DRUG WITHDRAWAL SYNDROME 3 0.0000
959 BONE PAIN 2 0.0000
960 BLADDER CANCER 2 0.0000
961 DRUG-INDUCED LIVER INJURY 1 0.0000
962 INFUSION RELATED REACTION 2 0.0000
963 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
964 DEVICE USE ERROR 1 0.0000
965 DEVICE MALFUNCTION 2 0.0000
966 SKIN BURNING SENSATION 2 0.0000
967 ACNE 2 0.0000
968 DIABETES MELLITUS 2 0.0000
969 CARDIAC FAILURE 2 0.0000
970 FOETAL EXPOSURE DURING PREGNANCY 2 0.0000
971 INJECTION SITE ERYTHEMA 3 0.0000
972 TREATMENT FAILURE 2 0.0000
973 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
974 CARDIO-RESPIRATORY ARREST 1 0.0000
975 SKIN EXFOLIATION 2 0.0000
976 COLITIS ULCERATIVE 1 0.0000
977 DEVICE ISSUE 2 0.0000
978 ECZEMA 1 0.0000
979 RHEUMATOID ARTHRITIS 2 0.0000
980 BLOOD CREATININE INCREASED 1 0.0000
981 DEVICE DIFFICULT TO USE 1 0.0000
982 COMPLETED SUICIDE 1 0.0000
983 INJECTION SITE PAIN 3 0.0000
984 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
985 EMOTIONAL DISTRESS 1 0.0000